FeesSafety
Pluang+
Home/Explore/US Market Price/Stocks/TECH
icon
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

BIO-TECHNE Corp (TECH) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

TECH trades at $72.69, near its 52-week high of $72.70, with a slight 24-hour decline of 0.03%. The stock shows a bullish technical signal supported by moving averages, while fundamentals reveal a high P/E of 62.66 and net income margin of 14.97%. Recent news highlights shareholder approval of its acquisition by Merck KGaA at $73.00 per share, pending completion.
The outlook is mixed: the acquisition offers near-term upside to the $73.00 buyout price, but execution risks and premium valuation pose challenges. Investors should weigh the certainty of the merger premium against potential delays or regulatory hurdles, with no analyst sell ratings reflecting cautious optimism.
Read full analysis

Key Stats

  • Market Cap
    $11.42B
  • Volume
    2,565,846
  • Sector
    Health
  • 52W High
    $72.71
  • 52W Low
    $43.31
  • Typical Hold Time
    65 Days
  • Enterprise Value
    $11.44B
  • Div Yield
    0.44%
  • Trading Activity
    -
$72.69
52W Low: $43.31
15 May 2026
52W High: $72.71
29 Oct 2026

Track BIO-TECHNE Corp (TECH) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, BIO-TECHNE Corp has traded between a low of $43.31 and a high of $72.71, highlighting its annual price range. Buy and sell BIO-TECHNE Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About BIO-TECHNE Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.

Most Recent News

Content is generated by Aura AI

Li Auto delivers 29,025 vehicles in October, launches new Li MEGA and Li i6 with advanced tech upgrades

Li Auto delivered 29,025 vehicles in October 2026, bringing total deliveries to over 1.86 million. The company introduced over 3,000 units of the new Li MEGA and launched the 2026 Li i6 model equipped with its proprietary Lianshan Battery and advance...

Market News
1 hour ago
Li Auto Inc.
Bullish
news icon
Li Auto delivers 29,025 vehicles in October, launches new Li MEGA and Li i6 with advanced tech upgrades

OmniAb achieves self-sustaining cash flow, aiming for break-even net cash use by 2026.

OmniAb has reached a point where it no longer needs investor funding to operate, achieving self-sustaining cash flow. The company’s portfolio includes contractually protected options on hundreds of programs, with potential milestones exceeding $3 bil...

Market News
4 hours ago
Seeking Alpha
Bullish
news icon
OmniAb achieves self-sustaining cash flow, aiming for break-even net cash use by 2026.

Emerson to raise dividends for 70th consecutive year, driven by strong business growth.

Emerson is expected to increase its dividend by 6.3–8.1%, marking 70 years of consecutive dividend growth. This increase is supported by the company's strategic shift towards higher-margin Intelligent Devices and Software & Control segments, which is...

5 hours ago
Seeking Alpha
Bullish
news icon
Emerson to raise dividends for 70th consecutive year, driven by strong business growth.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $11.42B
  • Volume
    2,565,846
  • Sector
    Health
  • 52W High
    $72.71
  • 52W Low
    $43.31
  • Typical Hold Time
    65 Days
  • Enterprise Value
    $11.44B
  • Div Yield
    0.44%
  • Trading Activity
    -
$72.69
52W Low: $43.31
15 May 2026
52W High: $72.71
29 Oct 2026

Track BIO-TECHNE Corp (TECH) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, BIO-TECHNE Corp has traded between a low of $43.31 and a high of $72.71, highlighting its annual price range. Buy and sell BIO-TECHNE Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!